Pressuring the CDC

In early 2025 a cache of internal CDC emails was released, exposing how HHS Secretary Robert F. Kennedy Jr. intervened in the agency’s public‑health work. The messages document a direct request to halt a nationwide flu‑vaccine advertising campaign, an effort framed as “informed consent” messaging but timed during the worst flu season in recent years.

CDC communications official Nicole Coffin recounted that senior HHS staff, including communications chief Andrew Nixon, delivered the request directly from the secretary. The emails warned of reputational risk and potential legal issues if the campaign continued, underscoring the tension between scientific guidance and political instruction.

Beyond advertising, the emails reveal a broader strategy to reshape vaccine policy. Kennedy Jr.’s team prepared to dismiss all 17 members of the Advisory Committee for Immunization Practices (ACIP), the body that sets national vaccine recommendations. Draft memos noted that the vacancy count was low and that new appointees aligned with the secretary’s agenda could be installed, effectively “de‑politicizing” the committee by placing allies in key positions.

The push to overhaul the committee coincided with a senior HHS aide’s memo demanding “absolute need for political review” of any major CDC decision. The memo instructed that both the secretary and his advisers must vet policy actions before they were public, a step that amplified political oversight of scientific recommendations.

These pressures culminated in the August 2024 removal of CDC Director Susan Monarez, who had been confirmed only weeks earlier. Monarez’s ouster coincided with the resignations of Deputy Chief Medical Officer Dr. Debra Houry and other senior scientists. In her testimony, Monarez alleged that Kennedy Jr. threatened her resignation unless she agreed to the advisor‑driven changes to the childhood immunization schedule and the removal of CDC scientists.

After the leadership shake‑up, the CDC reduced the recommended childhood immunizations from 17 to 11, reclassifying several vaccines for high‑risk groups only. Critics argued this could leave children vulnerable, while the administration defended the move as aligning with practices in other Western nations.

The released emails illustrate how political directives from the HHS secretary can override established public‑health processes, raising concerns about the independence of the nation’s disease‑control agency.